Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @BioProInsider
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BioProInsider
-
BioProcess Insider proslijedio/la je Tweet
Breaking: Catalent
$CTLT to buy Orgenesis'#celltherapy#CDMO biz Masthercell for $315m - story@BioProInsider Insider https://buff.ly/36PRRod pic.twitter.com/gdXg2Jb6nZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Just over a week ago we had our most loved & exciting Yacht Party for
#PLW2020 &#WSCS20! What an amazing night where $10,000 was raised for the@CF_Foundation
#advancedtherapies#celltherapy#genetherapy#healthcare#medicine#futureofmedicinepic.twitter.com/v0Qz5xUwUY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Lack of good
#CDMOs a factor for@KrystalBiotech in investing $70-90m into internal PA gene therapy plant https://buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Oklahoma has introduced a bill intended to ban the state from prescribing, administering, and making medicinal products and vaccines containing human DNAhttps://lnkd.in/dXqB-23
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
VGXI will make Inovio Pharmaceuticals’ investigational
#vaccine as part of a collaborative effort to halt the progress of the#coronavirus that has recently emerged in Chinahttps://lnkd.in/dXMHxsMHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report https://xconomy.com/national/2020/01/28/advanced-therapies-are-reshaping-biopharma-rd-kpmg-report/ … via
@xconomyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
It's here! Falcon CEO Susan Nichols’ annual roundup of top events within the cell and gene therapy space in 2019, from
@Phacilitate#PLW2020 Contains#CRISPR capacity, and#BigPharma M&A , but#patientaccess takes the top spot https://buff.ly/3aLsBmf pic.twitter.com/yCG1G6X0Wf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
And here is the full story from
@phacilitate courtesy of@BioProInsider 'CDMO aims ‘big’ in $1.2bn push to deliver capacity to cell & gene space' https://tinyurl.com/Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
FDA cell and gene therapy forecast ‘unlikely’ - the opinion from Phacilitate
#PLW2020 as number of commercialized therapeutics falls flat after dynamic 2017 https://buff.ly/2tFZyzK pic.twitter.com/9G029ZUYEv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Mixture of pride of advancement but disappointment in relatively few commercial cell and gene products is the feeling at this year’s
#phacilitate in miami. Article to come on@BioProInsiderHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
$IOVA iovance admits TIL therapies with 22 day manufacturing process and potential gene editing added will be very expensive, though refuses to say whether it will be Kymriah expensive or Zolgensma expensive, at#phacilitatepic.twitter.com/MePyouHcRD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Regeneron says it can now roll out a lot more bispecific antibody-based therapies including a new class of costimulatory bispecificshttps://lnkd.in/deR8KKn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Genetic disease-focused firms need infrastructure says
@Sarepta, which shared plans for a gene editing center of excellence at the@JPM2020 conferencehttps://lnkd.in/d-udkGuHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Merck CEO Ken Frazier
@JPM2020 views 2023 as the year firm will satiate the “incredible” global demand for#HPVvaccine Gardasilhttps://lnkd.in/dF646DPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
French VC firm
@Seventure is raising over €200m in a 2nd dedicated fund focused on the#microbiome and says the therapeutic space will mature within the next 3 yearshttps://lnkd.in/dW4J2qfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
On the first day of Christmas my leading
#bioprocess news site gave to me, a merger based on CAR-T... Check out@BioProInsider festive look back at 2019 https://buff.ly/374OHxn pic.twitter.com/wdS42W6AA1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight https://buff.ly/2S91A5y via
@xconomypic.twitter.com/DOJ1YehWrw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Oxford Biomedica will keep supplying
@Novartis with the vectors needed to make Kymriah and other CAR-T products under a 5-year deal extension https://buff.ly/2M9ZgHC pic.twitter.com/9iuFXZJSM9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
Hemophilia A-OK! Roche’s $4.3bn Spark buy - There is no risk of competitive harm between Roche’s approved hemophila A monoclonal antibody and Spark’s
#genetherapy candidates, says@FTC https://buff.ly/2M1FFJl pic.twitter.com/vzVqW3JWIT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioProcess Insider proslijedio/la je Tweet
a
@BioProInsider exclusive: WuXi Biologics establishes microbial fermentation platform after building up mammalian and#vaccine services - https://buff.ly/34qbAd9 pic.twitter.com/lNdzu2omod
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.